DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant
Chemoradiation Therapy for Head and Neck Cancer
Does the drug SGX942 (Dusquetide) help treat mucositis.
Basic Study Information
Purpose:Location: University of Rochester
This study is for people with squamous cell carcinoma (skin cancer) and mucositis.
Mucositis is the painful inflammation and ulceration of the mucous membranes lining
the digestive tract, usually as an adverse effect of chemotherapy and radiotherapy
treatment for cancer. This study will assess the efficacy of SGX942 compared to placebo
in decreasing the duration of severe oral mucositis in patients receiving chemoradiation
treatment for the treatment of head and neck cancer.
Study Reference #: NA
Lead Researcher (Principal Investigator)
Lead Researcher: Deepinder Singh
Study Contact InformationPhone: (609) 538-8200
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search